Miral, Genilyn C.

HRN: 28-13-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
MUPIROCIN 2%, 15G (TUBE)
11/23/2025
11/30/2025
TOPICAL
To Area
BID
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines